The following is an edited summary of an original article published on the Academy’s Coronavirus Information webpage. Until more evidence-based research is published, this summary can serve as a quick guide for audiological understanding, management, and counseling of COVID-19 survivors. The information is current as of February 21, 2022. Shifting Terminology There is no formal diagnostic label for a COVID-19 “long hauler”; however, several published papers have offered more than ten possible labels, including “COVID-19 syndrome” and “post-COVID-19 syndrome” (DiSogra, 2021). “Long COVID” seems to be the more popular label. “Brain fog” is a nonmedical term that describes the symptoms comparable to mild cognitive impairment and/or an auditory processing disorder (APD) (Centers for Disease Control and Prevention, 2021; DiSogra, 2022). Case History Considerations A new set of questions that detail the COVID-19 experiences of the patient needs to be developed to address some of the potential issues addressed in this article. Comorbidities and prior COVID-19 medical management must be considered because they can exacerbate a preexisting condition. In addition, numerous medications used to treat COVID-19 (e.g., hydroxychloroquine) may have ototoxic effects. To obtain information on a particular drug’s side effects, the following resources are recommended: www.rxlist.com, www.drugs.com, the drug’s manufacturer, and/or the patient’s pharmacist. The effects of COVID-19 on the central auditory system are not well understood. This content is an exclusive benefit for American Academy of Audiology members. If you're a member, log in and you'll get immediate access. Member Login If you're not yet a member, you'll be interested to know that joining not only gives you access to top-notch resources like this one, but also invitations to member-only events, inclusion in the member directory, participation in professional forums, and access to patient resources, tools, and continuing education. Join today!